Literature DB >> 22387310

Structural requirements of bile acid transporters: C-3 and C-7 modifications of steroidal hydroxyl groups.

Vidula Kolhatkar1, James E Polli.   

Abstract

The apical sodium dependent bile acid transporter (ASBT) and sodium-taurocholate cotransporting polypeptide (NTCP) are potential prodrug targets, but the structural requirements for these transporters are incompletely defined. The objective of this study was to evaluate the effect of C-3 and C-7 substitution on bile acid interaction with these bile acid transporters. Nineteen bile acid analogs were tested against ASBT and NTCP for binding, as well as translocation. Results indicated that ASBT and NTCP accommodated a wide range of substituents for binding, but all major C-7 modifications resulted in analogs that did not demonstrate active uptake by either ASBT or NTCP. A C-3 modification that was not tolerated at C-7 still afforded translocation via ASBT and NTCP, confirming the relative unacceptability of C-7 modification. Both ASBT and NTCP demonstrated a generally similar binding potency. Results suggest that drug conjugation to the C-3 hydroxyl group, rather than C-7, has potential to lead to a successful prodrug targeting ASBT and NTCP.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22387310      PMCID: PMC3319149          DOI: 10.1016/j.ejps.2012.02.012

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  37 in total

1.  Chlorambucil-taurocholate is transported by bile acid carriers expressed in human hepatocellular carcinomas.

Authors:  G A Kullak-Ublick; J Glasa; C Böker; M Oswald; U Grützner; B Hagenbuch; B Stieger; P J Meier; U Beuers; W Kramer; G Wess; G Paumgartner
Journal:  Gastroenterology       Date:  1997-10       Impact factor: 22.682

2.  Synthesis and biological evaluation of novel steroidal pyrazoles as substrates for bile acid transporters.

Authors:  Laxminarayan Bhat; Bernd Jandeleit; Tracy M Dias; Tristen L Moors; Mark A Gallop
Journal:  Bioorg Med Chem Lett       Date:  2005-01-03       Impact factor: 2.823

3.  Membrane topology of human ASBT (SLC10A2) determined by dual label epitope insertion scanning mutagenesis. New evidence for seven transmembrane domains.

Authors:  Antara Banerjee; Peter W Swaan
Journal:  Biochemistry       Date:  2006-01-24       Impact factor: 3.162

4.  Interaction of native bile acids with human apical sodium-dependent bile acid transporter (hASBT): influence of steroidal hydroxylation pattern and C-24 conjugation.

Authors:  Anand Balakrishnan; Stephen A Wring; James E Polli
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

5.  Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.

Authors:  Richard H Ho; Rommel G Tirona; Brenda F Leake; Hartmut Glaeser; Wooin Lee; Christopher J Lemke; Yi Wang; Richard B Kim
Journal:  Gastroenterology       Date:  2006-03-06       Impact factor: 22.682

6.  Influence of charge and steric bulk in the C-24 region on the interaction of bile acids with human apical sodium-dependent bile acid transporter.

Authors:  Anand Balakrishnan; Stephen A Wring; Andrew Coop; James E Polli
Journal:  Mol Pharm       Date:  2006 May-Jun       Impact factor: 4.939

Review 7.  Apical sodium dependent bile acid transporter (ASBT, SLC10A2): a potential prodrug target.

Authors:  Anand Balakrishnan; James E Polli
Journal:  Mol Pharm       Date:  2006 May-Jun       Impact factor: 4.939

8.  Substrate specificity of the ileal and the hepatic Na(+)/bile acid cotransporters of the rabbit. I. Transport studies with membrane vesicles and cell lines expressing the cloned transporters.

Authors:  W Kramer; S Stengelin; K H Baringhaus; A Enhsen; H Heuer; W Becker; D Corsiero; F Girbig; R Noll; C Weyland
Journal:  J Lipid Res       Date:  1999-09       Impact factor: 5.922

9.  Development of stably transfected monolayer overexpressing the human apical sodium-dependent bile acid transporter (hASBT).

Authors:  Anand Balakrishnan; Daniel J Sussman; James E Polli
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

10.  Bile acid uptake via the human apical sodium-bile acid cotransporter is electrogenic.

Authors:  S A Weinman; M W Carruth; P A Dawson
Journal:  J Biol Chem       Date:  1998-12-25       Impact factor: 5.157

View more
  14 in total

1.  Synthesis and Biological Evaluation of Bile Acid Analogues Inhibitory to Clostridium difficile Spore Germination.

Authors:  Kristen L Stoltz; Raymond Erickson; Christopher Staley; Alexa R Weingarden; Erin Romens; Clifford J Steer; Alexander Khoruts; Michael J Sadowsky; Peter I Dosa
Journal:  J Med Chem       Date:  2017-04-12       Impact factor: 7.446

2.  Synthesis and Evaluation of Bile Acid-Ribavirin Conjugates as Prodrugs to Target the Liver.

Authors:  Zhongqi Dong; Qing Li; Dong Guo; Yan Shu; James E Polli
Journal:  J Pharm Sci       Date:  2015-02-02       Impact factor: 3.534

Review 3.  Intestinal Absorption of Bile Acids in Health and Disease.

Authors:  Alexander L Ticho; Pooja Malhotra; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

4.  Design and characterization of a novel fluorinated magnetic resonance imaging agent for functional analysis of bile Acid transporter activity.

Authors:  Diana Vivian; Kunrong Cheng; Sandeep Khurana; Su Xu; Valerie Whiterock; Drew Witter; Kimberley A Lentz; Kenneth S Santone; Jean-Pierre Raufman; James E Polli
Journal:  Pharm Res       Date:  2013-01-15       Impact factor: 4.200

Review 5.  Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters.

Authors:  M Sawkat Anwer; Bruno Stieger
Journal:  Pflugers Arch       Date:  2013-10-03       Impact factor: 3.657

6.  Structure-activity relationship for FDA approved drugs as inhibitors of the human sodium taurocholate cotransporting polypeptide (NTCP).

Authors:  Zhongqi Dong; Sean Ekins; James E Polli
Journal:  Mol Pharm       Date:  2013-02-12       Impact factor: 4.939

7.  Synthesis and in vitro evaluation of bile acid prodrugs of floxuridine to target the liver.

Authors:  Diana Vivian; James E Polli
Journal:  Int J Pharm       Date:  2014-09-16       Impact factor: 5.875

8.  Design and evaluation of a novel trifluorinated imaging agent for assessment of bile acid transport using fluorine magnetic resonance imaging.

Authors:  Diana Vivian; Kunrong Cheng; Sandeep Khurana; Su Xu; Paul A Dawson; Jean-Pierre Raufman; James E Polli
Journal:  J Pharm Sci       Date:  2014-09-05       Impact factor: 3.534

9.  Quantitative NTCP pharmacophore and lack of association between DILI and NTCP Inhibition.

Authors:  Zhongqi Dong; Sean Ekins; James E Polli
Journal:  Eur J Pharm Sci       Date:  2014-09-16       Impact factor: 4.384

Review 10.  Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades.

Authors:  Alan F Hofmann; Lee R Hagey
Journal:  J Lipid Res       Date:  2014-05-17       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.